The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis
Open accessAbstract
Background and Aim: The magnitude of the risk of incident type 2 diabetes (T2D) and metabolic syndrome (MetS) among patients with nonalcoholic fatty liver disease (NAFLD) is poorly known. We gauged the risk of developing T2D and MetS in patients with NAFLD diagnosed by either serum liver enzymes (aminotransferases or gamma‐glutamyltransferase [GGT]) or ultrasonography. Methods: Pertinent prospective studies were identified through extensive electronic database research, and studies fulfilling enrolment criteria were included in the meta‐analysis. Results: Overall, in a pooled population of 117020 patients (from 20 studies), who were followed‐up for a median period of 5 years (range: 3–14.7 years), NAFLD was associated with an increased risk of incident T2D with a pooled relative risk of 1.97 (95% confidence interval [CI], 1.80–2.15) for alanine aminotransferase, 1.58 (95% CI, 1.43–1.74) for aspartate aminotransferase, 1.86 (95% CI, 1.71–2.03) for GGT (last vs first quartile or quintile), and 1.86 (95% CI, 1.76–1.95) for ultrasonography, respectively. Overall, in a pooled population of 81411 patients (from eight studies) who were followed‐up for a median period of 4.5 years (range: 3–11 years), NAFLD was associated with an increased risk of incident MetS with a pooled relative risk of 1.80 (95% CI, 1.72–1.89) for alanine aminotransferase (last vs first quartile or quintile), 1.98 (95% CI, 1.89–2.07) for GGT, and 3.22 (95% CI, 3.05–3.41) for ultrasonography, respectively. Conclusions: Nonalcoholic fatty liver disease, as diagnosed by either liver enzymes or ultrasonography, significantly increases the risk of incident T2D and MetS over a median 5‐year follow‐up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.11.008 · Cited by 17,893
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Self-citationLong-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972
Vozarova, B., Stefan, N., Lindsay, R. S., Saremi, A., Pratley, R. E., Bogardus, C., & Tataranni, P. A. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1889 · Cited by 717
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., & Loria, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.020 · Cited by 685
Self-citationCellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Kumashiro, N., Erion, D. M., Zhang, D., Kahn, M., Beddow, S. A., Chu, X., Still, C. D., Gerhard, G. S., Han, X., Dziura, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113359108 · Cited by 585
Lee, D. S., Evans, J. C., Robins, S. J., Wilson, P. W., Albano, I., Fox, C. S., Wang, T. J., Benjamin, E. J., D’Agostino, R. B., & Vasan, R. S. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000251993.20372.40 · Cited by 530
Lee, D.-H., Jacobs, D. R., Gross, M., Kiefe, C. I., Roseman, J., Lewis, C. E., & Steffes, M. (2003) · Clinical Chemistry · doi:10.1373/49.8.1358 · Cited by 457
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez-Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444
Self-citationLiver Markers and Development of the Metabolic Syndrome
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., & Haffner, S. M. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3140 · Cited by 419
Adams, L. A., Waters, O. R., Knuiman, M. W., Elliott, R. R., & Olynyk, J. K. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.67 · Cited by 413
Elevations in Markers of Liver Injury and Risk of Type 2 Diabetes
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., Kempf, J., Zinman, B., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2623 · Cited by 385
Alanine Aminotransferase, γ-Glutamyltransferase, and Incident Diabetes
Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Davey Smith, G., & Lawlor, D. A. (2009) · Diabetes Care · doi:10.2337/dc08-1870 · Cited by 385
Sattar, N., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Stanley, A., Forrest, E., MacFarlane, P. W., Packard, C. J., Cobbe, S. M., & Shepherd, J. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2855 · Cited by 375
Gamma-glutamyltransferase and diabetes—a 4 year follow-up study
Lee, D.-H., Ha, M.-H., Kim, J.-H., Christiani, D. C., Gross, M. D., Steffes, M., Blomhoff, R., & Jacobs, D. R. (2003) · Diabetologia · doi:10.1007/s00125-003-1036-5 · Cited by 344
From NAFLD in clinical practice to answers from guidelines
Nascimbeni, F., Pais, R., Bellentani, S., Day, C. P., Ratziu, V., Loria, P., & Lonardo, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.044 · Cited by 337
Self-citationAminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
Goessling, W., Massaro, J. M., Vasan, R. S., D'Agostino, R. B., Ellison, R. C., & Fox, C. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.018 · Cited by 330
Exercise or exercise and diet for preventing type 2 diabetes mellitus
Orozco, L. J., Buchleitner, A. M., Gimenez-Perez, G., Roqué i Figuls, M., Richter, B., & Mauricio, D. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003054.pub3 · Cited by 327
Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes
Nannipieri, M., Gonzales, C., Baldi, S., Posadas, R., Williams, K., Haffner, S. M., Stern, M. P., & Ferrannini, E. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1757 · Cited by 308
Nakanishi, N., Suzuki, K., & Tatara, K. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1427 · Cited by 304
Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older Men
Wannamethee, S. G., Shaper, A. G., Lennon, L., & Whincup, P. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2913 · Cited by 274
Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism
Meex, R. C., Hoy, A. J., Morris, A., Brown, R. D., Lo, J. C. Y., Burke, M., Goode, R. J. A., Kingwell, B. A., Kraakman, M. J., Febbraio, M. A., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.023 · Cited by 255
Nonalcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-Aged Japanese Men
Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M., & Otsuki, M. (2007) · Diabetes Care · doi:10.2337/dc07-0792 · Cited by 238
Bril, F., Ortiz‐Lopez, C., Lomonaco, R., Orsak, B., Freckleton, M., Chintapalli, K., Hardies, J., Lai, S., Solano, F., Tio, F., et al. (2015) · Liver International · doi:10.1111/liv.12840 · Cited by 237
Effects of nonalcoholic fatty liver disease on the development of metabolic disorders
Fan, J., Li, F., Cai, X., Peng, Y., Ao, Q., & Gao, Y. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04781.x · Cited by 193
Yamazaki, H., Tsuboya, T., Tsuji, K., Dohke, M., & Maguchi, H. (2015) · Diabetes Care · doi:10.2337/dc15-0140 · Cited by 172
Resolution of Fatty Liver and Risk of Incident Diabetes
Sung, K.-C., Wild, S. H., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1519 · Cited by 169
Chang, Y., Jung, H.-S., Yun, K. E., Cho, J., Cho, Y. K., & Ryu, S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.349 · Cited by 163
Cantley, J. L., Yoshimura, T., Camporez, J. P. G., Zhang, D., Jornayvaz, F. R., Kumashiro, N., Guebre-Egziabher, F., Jurczak, M. J., Kahn, M., Guigni, B. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219456110 · Cited by 161
Park, S. K., Seo, M. H., Shin, H. C., & Ryoo, J.-H. (2013) · Hepatology · doi:10.1002/hep.26183 · Cited by 158
Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study
Group Study D.E.S.I.R., Balkau, B., Lange, C., Vol, S., Fumeron, F., & Bonnet, F. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-56 · Cited by 153
Abnormal Liver Function Test Predicts Type 2 Diabetes
Cho, N. H., Jang, H. C., Choi, S. H., Kim, H. R., Lee, H. K., Chan, J. C. N., & Lim, S. K. (2007) · Diabetes Care · doi:10.2337/dc07-0106 · Cited by 152
André, P., Balkau, B., Vol, S., Charles, M.-A. A., Eschwège, É., & on behalf of the DESIR Study Group (2007) · Diabetes Care · doi:10.2337/dc07-0440 · Cited by 150
Monami, M., Bardini, G., Lamanna, C., Pala, L., Cresci, B., Francesconi, P., Buiatti, E., Rotella, C. M., & Mannucci, E. (2008) · Metabolism · doi:10.1016/j.metabol.2007.10.015 · Cited by 148
Liver Enzymes as a Predictor for Incident Diabetes in a Japanese Population: The Hisayama Study
Doi, Y., Kubo, M., Yonemoto, K., Ninomiya, T., Iwase, M., Tanizaki, Y., Shikata, K., Iida, M., & Kiyohara, Y. (2007) · Obesity · doi:10.1038/oby.2007.218 · Cited by 144
Ballestri, S., Romagnoli, D., Nascimbeni, F., Francica, G., & Lonardo, A. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1007955 · Cited by 122
Self-citationFatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults
Kim, C., Park, J.-Y., Lee, K.-U., Kim, J. H., & Kim, H. ‐. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02410.x · Cited by 118
Influence of non‐alcoholic fatty liver disease on the development of diabetes mellitus
Kasturiratne, A., Weerasinghe, S., Dassanayake, A. S., Rajindrajith, S., Silva, A. P. D., Kato, N., Wickremasinghe, A. R., & de Silva, H. J. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07264.x · Cited by 114
Arulanandan, A., Ang, B., Bettencourt, R., Hooker, J. C., Behling, C. A., Lin, G., Valasek, M. A., Ix, J. H., Schnabl, B., Sirlin, C. B., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.01.027 · Cited by 105
Magkos, F., Fabbrini, E., Mohammed, B. S., Patterson, B. W., & Klein, S. (2010) · Obesity · doi:10.1038/oby.2010.90 · Cited by 98
Liver Enzymes and Incident Diabetes
Ford, E. S., Schulze, M. B., Bergmann, M. M., Thamer, C., Joost, H., & Boeing, H. (2008) · Diabetes Care · doi:10.2337/dc07-2159 · Cited by 97
Zelber‐Sagi, S., Lotan, R., Shibolet, O., Webb, M., Buch, A., Nitzan, D., Halpern, Z., Santo, E., & Oren, R. (2013) · Liver International · doi:10.1111/liv.12200 · Cited by 96
Meisinger, C., Löwel, H., Heier, M., Schneider, A. L. C., Thorand, B., & FOR THE KORA STUDY GROUP (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01572.x · Cited by 94
André, P., Balkau, B., Born, C., Royer, B., Wilpart, E., Charles, M.-A. A., & Eschwège, É. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70229-x · Cited by 93
The association between liver enzymes and risk of type 2 diabetes: the Namwon study
Ahn, H.-R., Shin, M., Nam, H., Park, K.-S., Lee, Y. H., Jeong, S., Choi, J., & Kweon, S. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-14 · Cited by 91
Kim, C., Park, J., Lee, K., Kim, J.-H., & Kim, H. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.890 · Cited by 89
Onat, A., Can, G., Örnek, E., Çiçek, G., Ayhan, E., & Doğan, Y. (2011) · Obesity · doi:10.1038/oby.2011.136 · Cited by 84
Liver Enzymes Compared With Alcohol Consumption in Predicting the Risk of Type 2 Diabetes
Satō, K., Hayashi, T., Nakamura, Y., Harita, N., Yoneda, T., Endo, G., & Kambe, H. (2008) · Diabetes Care · doi:10.2337/dc07-2184 · Cited by 78
Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study
Schneider, A. L. C., Lazo, M., Ndumele, C. E., Pankow, J. S., Coresh, J., Clark, J. M., & Selvin, E. (2013) · Diabetic Medicine · doi:10.1111/dme.12187 · Cited by 77
Kunutsor, S. K., Apekey, T. A., & Seddoh, D. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12507 · Cited by 67
Liu, C.-F., Zhou, W., & Fang, N.-Y. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02959.x · Cited by 66
Jo, S.-K., Lee, W., Rhee, E., Won, J. C., Jung, C., Park, C., Oh, K.-W., Park, S., & Kim, S.-W. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.03.035 · Cited by 51
Olynyk, J. K., Knuiman, M. W., Divitini, M., Davis, T. M. E., Beilby, J. P., & Hung, J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.229 · Cited by 49
The Association of Fatty Liver and Diabetes Risk.
Okamoto, M., Takeda, Y., Yoda, Y., Kobayashi, K., Fujino, M., & Yamagata, Z. (2003) · Journal of Epidemiology · doi:10.2188/jea.13.15 · Cited by 49
Xu, Y., Bi, Y., Xu, M., Huang, Y., Lu, W., Yi-fu, G. U., Ning, G., & Xiao-ying, L. I. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00111.x · Cited by 45
Ryoo, J., Choi, J., Moon, S. Y., Suh, Y. J., Shin, J., Shin, H. C., & Park, S. K. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.002 · Cited by 44
Ming, J., Xu, S., Gao, B., Liu, G., Ji, Y., Yang, F., Jia, Y., Fang, Y., & Ji, Q. (2015) · Liver International · doi:10.1111/liv.12851 · Cited by 44
Liu, Z., Que, S., Ning, H., Wang, L., & Peng, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080596 · Cited by 39
Schindhelm, R. K., Dekker, J. M., Nijpels, G., Heine, R. J., & Diamant, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2812 · Cited by 35
Chitraju, C., Trötzmüller, M., Hartler, J., Wolinski, H., Thallinger, G., Haemmerle, G., Zechner, R., Zimmermann, R., Köfeler, H. C., & Spener, F. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m037952 · Cited by 35
Alanine Aminotransferase and Risk of the Metabolic Syndrome: A Linear Dose-Response Relationship
Kunutsor, S. K., & Seddoh, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096068 · Cited by 34
Ryu, S., Chang, Y., Woo, H., Yoo, S.-H., Choi, N., Lee, W., Kim, I., & Song, J. (2009) · Metabolism · doi:10.1016/j.metabol.2009.08.024 · Cited by 33
Zhang, T., Zhang, Y., Zhang, C., Tang, F., Li, H., Zhang, Q., Lin, H., Wu, S., Liu, Y., & Xue, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096651 · Cited by 31
Cicero, A. F. G., D’Addato, S., Reggi, A., Marchesini, G., & Borghi, O. B. O. T. B. C. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0147 · Cited by 30
Jiamjarasrangsi, W., Sangwatanaroj, S., Lohsoonthorn, V., & Lertmaharit, S. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.01.009 · Cited by 25
Ryoo, J., Oh, C., Kim, H. S., Park, S. K., & Choi, J. (2013) · Diabetic Medicine · doi:10.1111/dme.12315 · Cited by 23
Suh, Y. J., Park, S. K., Choi, J., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.029 · Cited by 15
Suh, B.-S. (2012) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2012.33.1.51 · Cited by 15
Elevated liver enzymes are related to progression to impaired glucose tolerance in Japanese men
Oka, R., Aizawa, T., Yagi, K., Hayashi, K., Kawashiri, M., & Yamagishi, M. (2013) · Diabetic Medicine · doi:10.1111/dme.12345 · Cited by 12
Association of Serum γ-Glutamyltransferase Level and Incident Prehypertension in Korean Men
Chun, H., Park, S. K., & Ryoo, J. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.11.1603 · Cited by 10
Cited by
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Metadata
- Authors
- Ballestri, S., Zona, S., Targher, G., Romagnoli, D., Baldelli, E., Nascimbeni, F., Roverato, A., Guaraldi, G., & Lonardo, A.
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2016-04-28
- Volume
- 31
- Issue
- 5
- Pages
- 936-944
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W2264982161
- Cited by
- 717
- References
- 76
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.